DOI QR코드

DOI QR Code

Mitochondrial tumor suppressor 1 is a target of AT-rich interactive domain 1A and progesterone receptor in the murine uterus

  • Chang, Hye Jin (Obstetrics, Gynecology & Reproductive Biology, Michigan State University) ;
  • Teasley, Hanna E. (Obstetrics, Gynecology & Reproductive Biology, Michigan State University) ;
  • Yoo, Jung-Yoon (Department of Biochemistry and Molecular Biology, Yonsei University College of Medicine) ;
  • Kim, Tae Hoon (Obstetrics, Gynecology & Reproductive Biology, Michigan State University) ;
  • Jeong, Jae-Wook (Obstetrics, Gynecology & Reproductive Biology, Michigan State University)
  • Received : 2017.12.30
  • Accepted : 2018.03.29
  • Published : 2018.08.01

Abstract

Objective: Progesterone receptor (PGR) and AT-rich interactive domain 1A (ARID1A) have important roles in the establishment and maintenance of pregnancy in the uterus. In present studies, we examined the expression of mitochondrial tumor suppressor 1 (MTUS1) in the murine uterus during early pregnancy as well as in response to ovarian steroid hormone treatment. Methods: We performed quantitative reverse transcription polymerase chain reaction and immunohistochemistry analysis to investigate the regulation of MTUS1 by ARID1A and determined expression patterns of MTUS1 in the uterus during early pregnancy. Results: The expression of MTUS1 was detected on day 0.5 of gestation (GD 0.5) and then gradually increased until GD 3.5 in the luminal and glandular epithelium. However, the expression of MTUS1 was significantly reduced in the uterine epithelial cells of $Pgr^{cre/+}Arid1a^{f/f}$ and Pgr knockout (PRKO) mice at GD 3.5. Furthermore, MTUS1 expression was remarkably induced after P4 treatment in the luminal and glandular epithelium of the wild-type mice. However, the induction of MTUS1 expression was not detected in uteri of $Pgr^{cre/+}Arid1a^{f/f}$ or PRKO mice treated with P4. Conclusion: These results suggest that MTUS1 is a novel target gene by ARID1A and PGR in the uterine epithelial cells.

Keywords

References

  1. Tabibzadeh S. Molecular control of the implantation window. Hum Reprod Update 1998; 4: 465-471. https://doi.org/10.1093/humupd/4.5.465
  2. Fox C, Morin S, Jeong JW, et al. Local and systemic factors and implantation: what is the evidence? Fertil Steril 2016;105:873-84. https://doi.org/10.1016/j.fertnstert.2016.02.018
  3. Bhurke AS, Bagchi IC, Bagchi MK. Progesterone-regulated endometrial factors controlling implantation. Am J Reprod Immunol 2016;75:237-45. https://doi.org/10.1111/aji.12473
  4. Adams NR, DeMayo FJ. The role of steroid hormone receptors in the establishment of pregnancy in rodents. Adv Anat Embryol Cell Biol 2015;216:27-49.
  5. Wetendorf M, DeMayo FJ. Progesterone receptor signaling in the initiation of pregnancy and preservation of a healthy uterus. Int J Dev Biol 2014;58:95-106. https://doi.org/10.1387/ijdb.140069mw
  6. Young SL, Lessey BA. Progesterone function in human endometrium: clinical perspectives. Semin Reprod Med 2010;28:5-16. https://doi.org/10.1055/s-0029-1242988
  7. Attia GR, Zeitoun K, Edwards D, et al. Progesterone receptor isoform A but not B is expressed in endometriosis. J Clin Endocrinol Metabol 2000;85:2897-902.
  8. Patel BG, Rudnicki M, Yu J, et al. Progesterone resistance in endometriosis: origins, consequences and interventions. Acta Obstet Gynecol Scand 2017;96:623-32. https://doi.org/10.1111/aogs.13156
  9. Wilson BG, Roberts CW. SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer 2011;11:481-92. https://doi.org/10.1038/nrc3068
  10. Wu JN, Roberts CW. ARID1A mutations in cancer: another epigenetic tumor suppressor? Cancer Discov 2013;3:35-43. https://doi.org/10.1158/2159-8290.CD-12-0361
  11. Kim TH, Yoo JY, Wang Z, et al. ARID1A is essential for endometrial function during early pregnancy. PLoS Genet 2015;11:e1005537. https://doi.org/10.1371/journal.pgen.1005537
  12. Bozgeyik I, Yumrutas O, Bozgeyik E. MTUS1, a gene encoding angiotensin-II type 2 (AT2) receptor-interacting proteins, in health and disease, with special emphasis on its role in carcinogenesis. Gene 2017;626:54-63. https://doi.org/10.1016/j.gene.2017.05.019
  13. Seibold S, Rudroff C, Weber M, et al. Identification of a new tumor suppressor gene located at chromosome 8p21.3-22. FASEB J 2003;17:1180-2. https://doi.org/10.1096/fj.02-0934fje
  14. Di Benedetto M, Bieche I, Deshayes F, et al. Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIP. Gene 2006;380:127-36. https://doi.org/10.1016/j.gene.2006.05.021
  15. Wruck CJ, Funke-Kaiser H, Pufe T, et al. Regulation of transport of the angiotensin AT2 receptor by a novel membrane-associated Golgi protein. Arterioscler Thromb Vasc Biol 2005;25:57-64.
  16. Ding X, Zhang N, Cai Y, et al. Down-regulation of tumor suppressor MTUS1/ATIP is associated with enhanced proliferation, poor differentiation and poor prognosis in oral tongue squamous cell carcinoma. Mol Oncol 2012; 6:73-80. https://doi.org/10.1016/j.molonc.2011.11.002
  17. Nouet S, Amzallag N, Li JM, et al. Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP. J Biol Chem 2004;279:28989-97. https://doi.org/10.1074/jbc.M403880200
  18. Whitaker AM, Molina PE. Angiotensin (1-7) contributes to nitric oxide tonic inhibition of vasopressin release during hemorrhagic shock in acute ethanol intoxicated rodents. Life Sci 2013;93:623-9. https://doi.org/10.1016/j.lfs.2013.08.020
  19. Zhao T, Ding X, Chang B, et al. MTUS1/ATIP3a down-regulation is associated with enhanced migration, invasion and poor prognosis in salivary adenoid cystic carcinoma. BMC Cancer 2015;15:203. https://doi.org/10.1186/s12885-015-1209-x
  20. Lydon JP, DeMayo FJ, Funk CR, et al. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 1995;9:2266-78. https://doi.org/10.1101/gad.9.18.2266
  21. Fernandez-Valdivia R, Jeong J, Mukherjee A, et al. A mouse model to dissect progesterone signaling in the female reproductive tract and mammary gland. Genesis 2010;48:106-13.
  22. Jones SR, Kimler BF, Justice WM, et al. Transit of normal rat uterine stromal cells through G1 phase of the cell cycle requires progesterone-growth factor interactions. Endocrinology 2000;141:637-48. https://doi.org/10.1210/endo.141.2.7332
  23. Burney RO, Talbi S, Hamilton AE, et al. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology 2007;148:3814-26. https://doi.org/10.1210/en.2006-1692
  24. Tan J, Paria BC, Dey SK, et al. Differential uterine expression of estrogen and progesterone receptors correlates with uterine preparation for implantation and decidualization in the mouse. Endocrinology 1999;140:5310-21. https://doi.org/10.1210/endo.140.11.7148
  25. Franco HL, Rubel CA, Large MJ, et al. Epithelial progesterone receptor exhibits pleiotropic roles in uterine development and function. FASEB J 2012;26:1218-27. https://doi.org/10.1096/fj.11-193334
  26. Rodrigues-Ferreira S, Di Tommaso A, Dimitrov A, et al. 8p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein underexpressed in invasive breast carcinoma of poor prognosis. PLoS One 2009;4:e7239. https://doi.org/10.1371/journal.pone.0007239
  27. Ping H, Guo L, Xi J, et al. Angiotensin II type 2 receptor-interacting protein 3a inhibits ovarian carcinoma metastasis via the extracellular HMGA2-mediated ERK/EMT pathway. Tumour Biol 2017;39:1010428317713389.
  28. Okeke MI, Okoli AS, Nilssen O, et al. Molecular characterization and phylogenetics of Fennoscandian cowpox virus isolates based on the p4c and atip genes. Virol J 2014;11:119. https://doi.org/10.1186/1743-422X-11-119
  29. Shain AH, Pollack JR. The spectrum of SWI/SNF mutations, ubiquitous in human cancers. PLoS One 2013;8:e55119. https://doi.org/10.1371/journal.pone.0055119
  30. Lessey BA, Young SL. Homeostasis imbalance in the endometrium of women with implantation defects: the role of estrogen and progesterone. Semin Reprod Med 2014;32:365-75. https://doi.org/10.1055/s-0034-1376355
  31. Bulun SE, Cheng YH, Yin P, et al. Progesterone resistance in endometriosis: link to failure to metabolize estradiol. Mol Cell Endocrinol 2006;248:94-103. https://doi.org/10.1016/j.mce.2005.11.041